Research progress of semaglutide in the treatment of obese type 2 diabetes mellitus with non-alcoholic fatty liver disease

ZHENG Jia, LI Qimeng, MING Yi#

主办：上海医药工业研究院
　　　中国药学会
ISSN 1672-9188   CN 31-1939/R   SLYHAA
World Clinical Drug
World Clinical Drug ›› 2026, Vol. 47 ›› Issue (1) : 99. DOI: 10.13683/j.wph.2026.01.015
Review

Research progress of semaglutide in the treatment of obese type 2 diabetes mellitus with non-alcoholic fatty liver disease

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2026, 47(1): 99 https://doi.org/10.13683/j.wph.2026.01.015

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}

Accesses

Citation

Detail
Sections
Recommended

/

〈 〉